Selected research
Industry Research
Venous Thromboembolism (VTE) Prevention Software Industry Research Report 2026
Market perspective
The global Venous Thromboembolism (VTE) Prevention Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Venous Thromboembolism (VTE) Prevention Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Venous Thromboembolism (VTE) Prevention Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Venous Thromboembolism (VTE) Prevention Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Venous Thromboembolism (VTE) Prevention Software include Aidoc, Xiangyu Medical, Xunfei Healthcare, Shanghai SYNYI AI, Shanghai Clinbrain, SmartCode Technology, Zhixuan Internet, Biovision Software and Lianyungang Xunda Seal Engraving Service, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Venous Thromboembolism (VTE) Prevention Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Venous Thromboembolism (VTE) Prevention Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Venous Thromboembolism (VTE) Prevention Software Market by Company
Aidoc
Xiangyu Medical
Xunfei Healthcare
Shanghai SYNYI AI
Shanghai Clinbrain
SmartCode Technology
Zhixuan Internet
Biovision Software
Lianyungang Xunda Seal Engraving Service
Donghua Medical Technology
Guangzhou Laino Information Technology
Venous Thromboembolism (VTE) Prevention Software Segment by Type
Cloud-based
On-premise
Venous Thromboembolism (VTE) Prevention Software Segment by Application
Hospital
Clinic
Other
Venous Thromboembolism (VTE) Prevention Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venous Thromboembolism (VTE) Prevention Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Venous Thromboembolism (VTE) Prevention Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venous Thromboembolism (VTE) Prevention Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Venous Thromboembolism (VTE) Prevention Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-premise
Applications
- Hospital
- Clinic
- Other
Companies covered
- Aidoc
- Xiangyu Medical
- Xunfei Healthcare
- Shanghai SYNYI AI
- Shanghai Clinbrain
- SmartCode Technology
- Zhixuan Internet
- Biovision Software
- Lianyungang Xunda Seal Engraving Service
- Donghua Medical Technology
- Guangzhou Laino Information Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Venous Thromboembolism (VTE) Prevention Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-based
- 2.2.3 On-premise
- 2.3 Venous Thromboembolism (VTE) Prevention Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Venous Thromboembolism (VTE) Prevention Software Breakdown Data by Type
- 3.1 Global Venous Thromboembolism (VTE) Prevention Software Historic Market Size by Type (2021-2026)
- 3.2 Global Venous Thromboembolism (VTE) Prevention Software Forecasted Market Size by Type (2027-2032)
4 Venous Thromboembolism (VTE) Prevention Software Breakdown Data by Application
- 4.1 Global Venous Thromboembolism (VTE) Prevention Software Historic Market Size by Application (2021-2026)
- 4.2 Global Venous Thromboembolism (VTE) Prevention Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Venous Thromboembolism (VTE) Prevention Software Market Perspective (2021-2032)
- 5.2 Global Venous Thromboembolism (VTE) Prevention Software Growth Trends by Region
- 5.2.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Venous Thromboembolism (VTE) Prevention Software Historic Market Size by Region (2021-2026)
- 5.2.3 Venous Thromboembolism (VTE) Prevention Software Forecasted Market Size by Region (2027-2032)
- 5.3 Venous Thromboembolism (VTE) Prevention Software Market Dynamics
- 5.3.1 Venous Thromboembolism (VTE) Prevention Software Industry Trends
- 5.3.2 Venous Thromboembolism (VTE) Prevention Software Market Drivers
- 5.3.3 Venous Thromboembolism (VTE) Prevention Software Market Challenges
- 5.3.4 Venous Thromboembolism (VTE) Prevention Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Venous Thromboembolism (VTE) Prevention Software Players by Revenue
- 6.1.1 Global Top Venous Thromboembolism (VTE) Prevention Software Players by Revenue (2021-2026)
- 6.1.2 Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Venous Thromboembolism (VTE) Prevention Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Venous Thromboembolism (VTE) Prevention Software Head Office and Area Served
- 6.4 Global Venous Thromboembolism (VTE) Prevention Software Players, Product Type & Application
- 6.5 Global Venous Thromboembolism (VTE) Prevention Software Manufacturers Established Date
- 6.6 Global Venous Thromboembolism (VTE) Prevention Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
- 7.2 North America Venous Thromboembolism (VTE) Prevention Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
- 7.4 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
- 8.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
- 8.4 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
- 9.2 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
- 10.2 South America Venous Thromboembolism (VTE) Prevention Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
- 10.4 South America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
- 11.2 Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aidoc
- 12.1.1 Aidoc Company Information
- 12.1.2 Aidoc Business Overview
- 12.1.3 Aidoc Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.1.4 Aidoc Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.1.5 Aidoc Recent Developments
- 12.2 Xiangyu Medical
- 12.2.1 Xiangyu Medical Company Information
- 12.2.2 Xiangyu Medical Business Overview
- 12.2.3 Xiangyu Medical Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.2.4 Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.2.5 Xiangyu Medical Recent Developments
- 12.3 Xunfei Healthcare
- 12.3.1 Xunfei Healthcare Company Information
- 12.3.2 Xunfei Healthcare Business Overview
- 12.3.3 Xunfei Healthcare Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.3.4 Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.3.5 Xunfei Healthcare Recent Developments
- 12.4 Shanghai SYNYI AI
- 12.4.1 Shanghai SYNYI AI Company Information
- 12.4.2 Shanghai SYNYI AI Business Overview
- 12.4.3 Shanghai SYNYI AI Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.4.4 Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.4.5 Shanghai SYNYI AI Recent Developments
- 12.5 Shanghai Clinbrain
- 12.5.1 Shanghai Clinbrain Company Information
- 12.5.2 Shanghai Clinbrain Business Overview
- 12.5.3 Shanghai Clinbrain Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.5.4 Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.5.5 Shanghai Clinbrain Recent Developments
- 12.6 SmartCode Technology
- 12.6.1 SmartCode Technology Company Information
- 12.6.2 SmartCode Technology Business Overview
- 12.6.3 SmartCode Technology Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.6.4 SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.6.5 SmartCode Technology Recent Developments
- 12.7 Zhixuan Internet
- 12.7.1 Zhixuan Internet Company Information
- 12.7.2 Zhixuan Internet Business Overview
- 12.7.3 Zhixuan Internet Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.7.4 Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.7.5 Zhixuan Internet Recent Developments
- 12.8 Biovision Software
- 12.8.1 Biovision Software Company Information
- 12.8.2 Biovision Software Business Overview
- 12.8.3 Biovision Software Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.8.4 Biovision Software Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.8.5 Biovision Software Recent Developments
- 12.9 Lianyungang Xunda Seal Engraving Service
- 12.9.1 Lianyungang Xunda Seal Engraving Service Company Information
- 12.9.2 Lianyungang Xunda Seal Engraving Service Business Overview
- 12.9.3 Lianyungang Xunda Seal Engraving Service Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.9.4 Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.9.5 Lianyungang Xunda Seal Engraving Service Recent Developments
- 12.10 Donghua Medical Technology
- 12.10.1 Donghua Medical Technology Company Information
- 12.10.2 Donghua Medical Technology Business Overview
- 12.10.3 Donghua Medical Technology Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.10.4 Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.10.5 Donghua Medical Technology Recent Developments
- 12.11 Guangzhou Laino Information Technology
- 12.11.1 Guangzhou Laino Information Technology Company Information
- 12.11.2 Guangzhou Laino Information Technology Business Overview
- 12.11.3 Guangzhou Laino Information Technology Revenue in Venous Thromboembolism (VTE) Prevention Software Business (2021-2026)
- 12.11.4 Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
- 12.11.5 Guangzhou Laino Information Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst